Platinum Priority – GuidelinesEditorial by Rodolfo Montironi, Liang Cheng, Marina Scarpelli and Antonio Lopez-Beltran on pp. 120–123 of this issueThe 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours
Section snippets
The new prostate tumour classification
The aim of this review is to summarize the new additions to the 2016 World Health Organization (WHO) classification (WHO “blue book”) compared with the 2004 WHO classification, with emphasis on a new entity, new variants of acinar adenocarcinoma, and new imunohistochemical stains for diagnosis, grading, risk stratification, and molecular genetics of acinar adenocarcinoma of the prostate. The 2016 WHO classification of tumours of the prostate [1] is summarized in Figure 1.
The new bladder tumour classification
The fourth edition of the WHO classification of tumours of the urothelial tract provides a contemporary review of the morphology of urothelial neoplasms, emphasizing their unique ability to exhibit divergent differentiation, multiple morphologic variants, and a diverse genomic landscape (Fig. 4) [1]. It is becoming clearer how both morphology and genotype may be exploited to select therapy, and for the latter, clinical protocols are in place to take advantage of activated molecular pathways in
References (136)
Intraductal carcinoma of the prostate
J Urol
(2015)- et al.
Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings
J Urol
(2010) - et al.
Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
Mod Pathol
(2006) - et al.
A contemporary prostate cancer grading system: a validated alternative to the Gleason score
Eur Urol
(2016) - et al.
The association of the cribriform pattern with outcome for prostatic adenocarcinomas
Pathol Res Pract
(2014) - et al.
Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer
Mod Pathol
(2015) - et al.
Clinical utility of quantitative Gleason grading in prostate biopsies and prostatectomy specimens
Eur Urol
(2016) - et al.
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer
Eur Urol
(2016) - et al.
The mutational landscape of prostate cancer
Eur Urol
(2013) - et al.
Integrative clinical genomics of advanced prostate cancer
Cell
(2015)
The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?
Crit Rev Oncol Hematol
Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts
J Urol
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network
Eur Urol
ICUD-EAU International Consultation on Bladder Cancer 2012: pathology
Eur Urol
Update for the practicing pathologist: the International Consultation on Urologic Disease-European Association of Urology consultation on bladder cancer
Mod Pathol
Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
Am J Pathol
Papillary urothelial hyperplasia: relationship to urothelial neoplasms
Pathology.
Cystectomy for bladder cancer: a contemporary series
J Urol
Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis
J Urol
The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma
J Urol
Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy
Eur J Cancer
Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases
Hum Pathol
Sarcomatoid carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical analysis of 14 patients
Hum Pathol
Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection
Mod Pathol
Long-term results of primary adenocarcinoma of the urinary bladder: A report on 192 patients
Urol Oncol
Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases
Mod Pathol
Unusual forms of carcinoma of the urinary bladder
Hum Pathol
Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases
Pathology
Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder
J Urol
Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome
Mod Pathol
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes
Urology
Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread
J Urol
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis
J Urol
Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder
Hum Pathol
The histogenesis of clear cell adenocarcinoma of the lower urinary tract. Case series and review of the literature
Hum Pathol
WHO Classification of Tumours of the Urinary System and Male Genital Organs
Ductal spread in prostatic carcinoma
Cancer
Intraductal carcinoma of the prostate: morphologic features, differential diagnoses, significance, and reporting practices
Arch Pathol Lab Med
Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations
Am J Surg Pathol
Intraductal carcinoma of the prostate: a comprehensive and updated review
Int J Urol
Intraductal carcinoma of the prostate
Arch Pathol Lab Med
Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study
Histopathology
Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between “precursor-like” and “regular type” lesions
Int J Clin Exp Pathol
Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy
Am J Surg Pathol
Histological variants of prostatic carcinoma and their significance
Histopathology
Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns
Am J Surg Pathol
Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases
Am J Surg Pathol
Pleomorphic giant cell carcinoma of the prostate
Arch Pathol Lab Med
Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer
Am J Surg Pathol
Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference
Am J Surg Pathol
Cited by (1099)
On Complete Clinical Response of Basal Cell Carcinoma of the Prostate After Definitive Concurrent Chemoradiation
2024, Advances in Radiation OncologyThe presence of intraductal carcinoma of prostate is a risk factor for poor pathologic response in men with high-risk prostate cancer receiving neoadjuvant therapy
2024, Urologic Oncology: Seminars and Original InvestigationsSurvival impact of variant histology in patients with upper tract urothelial carcinoma after radical nephroureterectomy
2024, Urologic Oncology: Seminars and Original Investigations